Niktimvo

Indicated For

chronic graft-versus-host disease, cGVHD

About This Medication

# IncyteCARES for Niktimvo Patient Guide: How to Get Niktimvo (axatilimab-csfr) at Low or No Cost ## About Niktimvo (axatilimab-csfr) Niktimvo is a prescription medication used to treat chronic graft-versus-host disease (cGVHD) in adults and children weighing at least 88.2 pounds (40 kg) who have already tried at least 2 other treatments that did not work.[4] It is the first and only CSF-1R-targeting monoclonal antibody approved for this condition.[5] In clinical trials, 75% of patients treated with Niktimvo showed positive responses to treatment.[5] ## Who Qualifies for IncyteCARES for Niktimvo The IncyteCARES for Niktimvo program offers multiple support options depending on your insurance status and financial situation:[1][2] **Patient Assistance Program (PAP):** Free medication is available to eligible patients who are **uninsured or underinsured** for Niktimvo.[1] **Savings Program:** Eligible patients with **commercial prescription drug coverage** can pay as little as $0 per month, subject to certain limits and an annual benefit maximum.[1][7] **Temporary Coverage:** If you have insurance coverage delays, eligible patients can receive a free short-term supply of Niktimvo while waiting for authorization.[1] ## Income Eligibility While specific income thresholds are not publicly detailed, the program evaluates eligibility based on household income for uninsured and underinsured patients.[2] During enrollment, IncyteCARES representatives will ask questions to determine your eligibility and may request verification of your current household income if you qualify.[2] **Important Note:** Government insurance programs like Medicare and Medicaid are typically ineligible for the savings program, though patients on these programs may qualify for other assistance options.[1] ## Insurance Requirements | Insurance Type | Eligibility | Program Option | |---|---|---| | Uninsured | Yes | Patient Assistance Program (free medication) | | Underinsured | Yes | Patient Assistance Program or Savings Program | | Commercial Insurance | Yes | Savings Program ($0/month copay option) | | Medicare | Limited | May qualify for other support services | | Medicaid | Limited | May qualify for other support services | If you have commercial insurance, IncyteCARES can help verify your coverage, explain your plan, assist with prior authorization requirements, and help appeal insurance denials or restrictions.[1] ## Step-by-Step Application Process **Step 1: Gather Required Documents** Before calling, have the following information ready:[2] - Valid prescription for Niktimvo from your healthcare provider - Current insurance information (if applicable) - Proof of residency - Proof of income (pay stubs, tax returns, or benefit statements) **Step 2: Call IncyteCARES** Contact the IncyteCARES for Niktimvo team at **1-855-452-5234**, Monday through Friday, 8 AM–8 PM ET.[1][2] **Step 3: Initial Assessment** A representative will ask you questions to determine your eligibility for savings or financial assistance programs.[2] Be prepared to discuss your insurance coverage, household income, and any out-of-pocket costs you're facing. **Step 4: Eligibility Verification** If you appear to qualify, IncyteCARES will verify your household income and confirm your eligibility for the appropriate program.[2] **Step 5: Enrollment and Support** Once enrolled, the team will review your insurance coverage for Niktimvo, explain additional support resources available during your treatment, and provide ongoing assistance.[2] ## Timeline and Medication Delivery While specific processing times are not detailed in program materials, IncyteCARES works to minimize delays in getting you your medication.[1] Medication is typically shipped directly to you or your physician's office.[1] If you experience insurance coverage delays, eligible patients can receive a free short-term supply while authorization is being processed.[1] ## What Happens If You're Denied If you do not qualify for the IncyteCARES for Niktimvo Savings or Patient Assistance Programs, the team may be able to provide information about other independent organizations or foundations that offer support.[2] These nonprofit organizations sometimes provide help with medicine costs, transportation or lodging expenses related to treatment, or counseling services offered at reduced or no cost.[2] ## Reauthorization and Refills Your program benefits require **reauthorization** to continue receiving assistance.[1] IncyteCARES will work with you to manage ongoing coverage and support throughout your treatment. Authorization is typically issued for 12-month periods, after which you'll need to reapply.[6][8] ## Important Program Limitations - An **annual benefit maximum** applies to the savings and assistance programs.[1][7] - You are responsible for any out-of-pocket costs above the maximum annual program benefit.[7] - Program benefits apply to **medication cost only** and do not cover costs to administer the medication.[2][7] - You must have a **valid prescription** for Niktimvo for an FDA-approved indication or compendia-recognized use.[1] - Patients must have a **minimum out-of-pocket cost of $0.01** to redeem the savings offer.[7] ## Get Started Today Don't let cost be a barrier to your treatment. Contact IncyteCARES for Niktimvo today to learn about your options: **Phone:** 1-855-452-5234 **Hours:** Monday–Friday, 8 AM–8 PM ET **Website:** www.IncyteCARES.com The IncyteCARES team is ready to help you understand your coverage options, explore financial assistance, and provide support throughout your treatment with Niktimvo. ## Disclaimer This guide provides general information about the IncyteCARES for Niktimvo Patient Assistance Program based on current program details. Program terms, benefits, and eligibility requirements may change at any time. For the most current and complete information, please contact IncyteCARES directly or visit www.IncyteCARES.com. This guide is not a substitute for professional medical or financial advice. Please consult with your healthcare provider and the IncyteCARES team regarding your specific situation.

Program information last verified: March 30, 2026